Showing results (11-20 of 47) with videos related to

Sort By:
Pageof 5
Arthritis Care & Research|April 11, 2023
Impact of Television Depictions of Gout on Perceptions of Illness: A Randomized Controlled TrialRachel Murdoch, Borislav Mihov, Anne M Horne, et al.
Calcified Tissue International|January 4, 2020
Zoledronate Slows Weight Loss and Maintains Fat Mass in Osteopenic Older Women: Secondary Analysis of a Randomized Controlled TrialIan R Reid, Anne M Horne, Borislav Mihov, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|January 22, 2026
Decreased Nonvertebral Fracture Incidence with Zoledronate Use For >3 Years: Post Hoc Analysis of an RCTIan R Reid, Anne M Horne, Borislav Mihov, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|September 2, 2022
Zoledronate Reduces Height Loss Independently of Vertebral Fracture Occurrence in a Randomized Trial in Osteopenic Older WomenIan R Reid, Sonja Bastin, Anne M Horne, et al.
The Journal of Clinical Endocrinology and Metabolism|March 22, 2019
Dietary Calcium Intake and Bone Loss Over 6 Years in Osteopenic Postmenopausal WomenSarah M Bristow, Anne M Horne, Greg D Gamble, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|October 12, 2019
Effects of Zoledronate on Cancer, Cardiac Events, and Mortality in Osteopenic Older WomenIan R Reid, Anne M Horne, Borislav Mihov, et al.
Bone|October 4, 2005
Fat mass is an important predictor of parathyroid hormone levels in postmenopausal womenMark J Bolland, Andrew B Grey, Ruth W Ames, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|August 25, 2020
Predictors of Fracture in Older Women With Osteopenic Hip Bone Mineral Density Treated With ZoledronateIan R Reid, Anne M Horne, Borislav Mihov, et al.
Pageof 5